These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15660429)

  • 1. Reduced plasma adiponectin in NASH: central obesity as an underestimated causative risk factor.
    Tietge UJ; Schmidt HH; Schütz T; Dippe P; Lochs H; Pirlich M
    Hepatology; 2005 Feb; 41(2):401; author reply 401-2. PubMed ID: 15660429
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease.
    Madan P
    CMAJ; 2005 Sep; 173(7):734-5; author reply 735. PubMed ID: 16186570
    [No Abstract]   [Full Text] [Related]  

  • 3. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
    Targher G; Bertolini L; Rodella S; Lippi G; Franchini M; Zoppini G; Muggeo M; Day CP
    Obesity (Silver Spring); 2008 Jun; 16(6):1394-9. PubMed ID: 18369343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non-diabetic Japanese patients with schizophrenia.
    Matsuda Y; Tanioka T; Yoshioka T; Nagano T; Hiroi T; Yoshikawa K; Okabe K; Nagamine I; Takasaka Y
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):266-73. PubMed ID: 15896219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women.
    Kwon K; Jung SH; Choi C; Park SH
    Int J Cardiol; 2005 Jun; 101(3):385-90. PubMed ID: 15907405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease.
    Musso G; Gambino R; Durazzo M; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Rabbione L; Premoli A; Cassader M; Pagano G
    Hepatology; 2005 Nov; 42(5):1175-83. PubMed ID: 16231364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.
    Hung YJ; Chen YC; Pei D; Kuo SW; Hsieh CH; Wu LY; He CT; Lee CH; Fan SC; Sheu WH
    Diabet Med; 2005 Aug; 22(8):1024-30. PubMed ID: 16026368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis.
    Kaser S; Moschen A; Kaser A; Ludwiczek O; Ebenbichler CF; Vogel W; Jaschke W; Patsch JR; Tilg H
    J Intern Med; 2005 Sep; 258(3):274-80. PubMed ID: 16115302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.
    Liu CJ; Chen PJ; Jeng YM; Huang WL; Yang WS; Lai MY; Kao JH; Chen DS
    J Hepatol; 2005 Aug; 43(2):235-42. PubMed ID: 15964656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
    Herrmann BL; Saller B; Stratmann M; Berg C; Mann K; Janssen OE
    Horm Metab Res; 2005 Jan; 37(1):49-52. PubMed ID: 15702440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea.
    Wolk R; Svatikova A; Nelson CA; Gami AS; Govender K; Winnicki M; Somers VK
    Obes Res; 2005 Jan; 13(1):186-90. PubMed ID: 15761179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low plasma adiponectin levels predict progression of coronary artery calcification.
    Maahs DM; Ogden LG; Kinney GL; Wadwa P; Snell-Bergeon JK; Dabelea D; Hokanson JE; Ehrlich J; Eckel RH; Rewers M
    Circulation; 2005 Feb; 111(6):747-53. PubMed ID: 15699257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
    Coenen KR; Hasty AH
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study.
    Vuppalanchi R; Marri S; Kolwankar D; Considine RV; Chalasani N
    J Clin Gastroenterol; 2005 Mar; 39(3):237-42. PubMed ID: 15718867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis.
    Floreani A; Variola A; Niro G; Premoli A; Baldo V; Gambino R; Musso G; Cassader M; Bo S; Ferrara F; Caroli D; Rizzotto ER; Durazzo M
    Am J Gastroenterol; 2008 Aug; 103(8):1959-65. PubMed ID: 18564121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels.
    Sohara N; Takagi H; Kakizaki S; Sato K; Mori M
    Liver Int; 2005 Feb; 25(1):28-32. PubMed ID: 15698395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.
    Becker B; Kronenberg F; Kielstein JT; Haller H; Morath C; Ritz E; Fliser D;
    J Am Soc Nephrol; 2005 Apr; 16(4):1091-8. PubMed ID: 15743998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum adiponectin concentrations during a 72-hour fast in over- and normal-weight humans.
    Merl V; Peters A; Oltmanns KM; Kern W; Born J; Fehm HL; Schultes B
    Int J Obes (Lond); 2005 Aug; 29(8):998-1001. PubMed ID: 15917861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.